Lichen sclerosus et atrophicus
DOI: https://doi.org/10.29296/25877305-2018-08-07
Issue:
8
Year:
2018
The paper presents an update on lichen sclerosus et atrophicus (its etiology and pathogenesis, clinical presentations, classification, differential diagnosis, and treatment), a chronic autoimmune dermatosis, one of the clinical variants of circumscribed scleroderma.
Keywords:
dermatology
circumscribed scleroderma
lichen sclerosus et atrophicus
anogenital localization
vulvar lichen
penile lichen
sexually transmitted infections
treatment
References:
- Guseva N.G. Sistemnaja sklerodermija – mul'tidistsiplinarnaja problema // Nauchno-prakt. revmatol. – 2011; 2: 10–4.
- Higgins C., Cruickshank M. A population-based case-control study of aetiological factors associated with vulval lichen sclerosus // J. Obstet. Gynaecol. – 2012; 32: 271–5.
- McPherson T., Cooper S. Vulval lichen sclerosus and lichen planus // Dermatol. Ther. – 2010; 23: 523–32.
- Edmonds E., Hunt S., Hawkins D. et al. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients // J. Eur. Acad. Dermatol. Venereol. – 2012; 26: 730–7.
- Molochkov V.A., Snarskaja E.S., Romashkina A.S. Ochagovaja sklerodermija, assotsiirovannaja s drugimi autotimmunnymi zabolevanijami i spektrom razlichnyh autoantitel // Ros. zhurn. kozhnyh i venericheskih boleznej. – 2011; 4: 33–6.
- Goldstein A., Marinoff S., Christopher K. et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice // J. Reprod. Med. – 2005; 50: 477–80.
- Kreuter A., Kryvosheyeva Y., Terras S. et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients // Acta Derm. Venereol. – 2013; 93: 238–41.
- Powell J., Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem // J. Am. Acad. Dermatol. – 2001; 44: 803–6.
- Kizer W., Prarie T., Morey A. Balanitis xerotica obliterans: epidemiologic distribution in an equal access health care system // South Med. J. – 2003; 96: 9–11.
- Nelson D., Peterson A. Lichen sclerosus: epidemiological distribution in an equal access health care system // J. Urol. – 2011; 185: 522–5.
- Bleeker M., Visser P., Overbeek L. et al. Lichen sclerosus: Incidence and risk of vulvar squamous cell carcinoma // Cancer Epidemiol. Biomark. Prev. – 2016; 25: 1224–30.
- Kirtschig G., Kuik D. A Dutch cohort study confirms familial occurrence of anogenital lichen sclerosus // J. Women’s Health Care. – 2014; 3: 209–11.
- Sokolova A.A, Grebenjuk V.N., Dolja O.V. Klinicheskie osobennosti genital'nogo skleroatroficheskogo lihena u muzhchin i zhenschin // Klin. dermatol. i venerol. – 2016; 1: 54–9.
- Smith S., Fischer G. Childhood onset vulvar lichen sclerosus does not resolve at puberty: A prospective case series // Pediatr. Dermatol. – 2009; 26: 725–9.
- Sokolova A.A., Grebenjuk V.N., Dolja O.V. Klinicheskaja harakteristika skleroatroficheskogo lihena u detej // Klin. dermatol. i venerol. – 2015; 1: 75–8.
- Padmavathy L., Lakshmana Rao, Dana Laksnmi et al. Lichen sclerosus et atrophicus in the Areolae: A case report // Case Rep. Dermatol. Med. – 2012; 3: 1–3.
- Sherman V., McPherson T., Baldo M. et al. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study // J. Eur. Acad. Dermatol. Venereol. – 2010; 24: 1031–4.
- Birenbaum D., Young R. High prevalence of thyroid disease in patients with lichen sclerosus // J. Reprod. Med. – 2007; 52: 28–30.
- Murphy R. Lichen sclerosus // Dermatol. Clin. – 2010; 28: 707–15.
- Leese G., Flynn R., Jung R. et al. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS) // Clin. Endocrinol. (Oxf). – 2008; 68: 311–6.
- Hofer M., Meeks J., Mehdiratta N. et al. Lichen sclerosus in men is associated with elevated body mass index, diabetes mellitus, coronary artery disease and smoking // World J. Urol. – 2014; 32: 105–8.
- Gao X., Barnardo M., Winsey S. et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus // J. Invest. Dermatol. – 2005; 125: 895–9.
- Howard A., Dean D., Cooper S. et al. Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva // Aust. J. Dermatol. – 2004; 45: 12–5.
- Baldo M., Bailey A., Bhogal B. et al. T-cells reactive with the NC16A domain of BP180 are present in vulval lichen sclerosus and lichen planus // J. Eur. Acad. Dermatol. Venereol. – 2010; 24: 186–90.
- Gambichler T., Hoxtermann S., Skrygan M. et al. Occurrence of circulating anti-bullous pemphigoid antibodies in patients with lichen sclerosus // J. Eur. Acad. Dermatol. Venereol. – 2011; 25: 369–70.
- Gambichler T., Terras S., Kreuter A. et al. Altered global methylation and hydroxymethylation status in vulvar lichen sclerosus – further support for epigenetic mechanisms // Br. J. Dermatol. – 2014; 170: 687–93.
- Patsatsi A., Kyriakou A., Mantas A. et al. Circulating anti-BP180 NC16a and anti-BP230 autoantibodies in patients with genital lichen sclerosus do not correlate with the disease activity and pruritus // Acta Dermatol. Venereol. – 2014; 94: 711–2.
- Abdelbaky A., Aluru P., Keegan P. et al. Development of male genital lichen sclerosus in penile reconstruction skin grafts after cancer surgery: an unreported complication // BJU Int. – 2012; 109: 776–9.
- Neill S., Lewis F., Tatnall F. et al. British Association of Dermatologists guidelines for the management of lichen sclerosus 2010 // Br. J. Dermatol. – 2010; 163: 672–82.
- Rimoin L., Kwatra S., Yosipovitch G. Female-specific pruritus from childhood to post- menopause: clinical features, hormonal factors, and treatment considerations // Dermatol. Ther. – 2013; 26 (2): 157–67.
- Taylor A., Guzail M., Al-Azzawi F. Differential expression of oestrogen receptor isoforms and androgen receptor in the normal vulva and vagina compared with vulval lichen sclerosus and chronic vaginitis // Br. J. Dermatol. – 2008; 158 (2): 319–28.
- Burova E.A. Skleroatroficheskij lihen vul'vy u detej. Osobennosti kliniki, patogeneza, lechenija. Avtoref. dis. ... kand. med. nauk. M., 1989.
- Aidé S., Lattario F., Almeida G. et al. Epstein-Barr virus and human papillomavirus infection in vulvar lichen sclerosus // J. Low Genit. Tract. Dis. – 2010; 14 (4): 319–22.
- Stepanova E.V. Papillomovirusnaja infektsija pri skleroticheskom lishae i rake vul'vy. Avtoref. dis. ... kand. med. nauk. M., 2004.
- Reutskaja M.A., Kulinich S.I. Rol' infektsij v geneze zabolevanij vul'vy // Sib. med. zhurn. – 2010; 6: 239–42.
- Sharapova L.E. K voprosu ob etiologii i patogeneze hronicheskih distroficheskih zabolevanij vul'vy // Ros. vestn. akush. i ginekol. – 2010; 1: 29–34.
- Bono W., Dupin N. Localized scleroderma (morphea) // Presse Med. – 2007; 19 (Suppl. 2): 32–7.
- Dvornikov A.S. Terapija bol'nyh lokalizovannoj sklerodermiej preparatom gialuronidazy // Vestn. dermatol. i venerol. – 2013; 3: 96–100.
- Wallace H. Lichen sclerosus et atrophicus. Transactions’s of the St. John’s Hospital // Dermatol. Soc. – 1971; 57: 9–30.
- Cooper S., Gao X., Powell J. et al. Does treatment of vulvar lichen sclerosus influence its prognosis? // Arch. Dermatol. – 2004; 140: 702–6.
- Simpkin S., Oakley A. Clinical review of 202 patients with vulval lichen sclerosus: a possible association with psoriasis // Australas J. Dermatol. – 2007; 48: 28–31.
- Bunker C. Zabolevanija polovyh organov u muzhchin. V kn.: Dermatologija Fitspatrika v klinicheskoj praktike. V 3 t. K. Vol'f, L.A. Gol'dmit, S.I. Kats i dr. Per. s angl. Pod obsch. red. akad. A.A. Kubanovoj / M.: Izdatel'stvo Panfilova: BINOM. Laboratorija znanij, 2012; 1202: 731–2.
- Krjazheva S.S., Romashkina A.S. Porazhenie naruzhnyh polovyh organov pri razlichnyh formah ogranichennoj sklerodermii // Aktual'nye voprosy dermatovenerologii i dermatoonkologii. – 2009; 6: 49–50.
- Schlosser B., Mirowski G. Lichen sclerosus and lichen planus in women and girls // Clin. Obstet. Gynecol. – 2015; 58: 125–42.
- Chiang K., Chang K., Wong T. et al. Linear scleroderma «en coup de sabre»: initial presentation as intractable partial seizures in a child // Pediatr. Neonatol. – 2009; 50: 294–8.
- Torgerson R. Zabolevanija polovyh organov u zhenschin. V kn.: Dermatologija Fitspatrika v klinicheskoj praktike. V 3 t. K. Vol'f, L.A. Gol'dmit, S.I. Kats i dr. Per. s angl. Pod obsch. red. akad. A.A. Kubanovoj / M.: Izdatel'stvo Panfilova: BINOM. Laboratorija znanij, 2012; T. 1: 42–3.
- Pugliese J., Morey A., Peterson A. Lichen sclerosus: review of literature and current recommendations for management // J. Urol. – 2007; 178: 2268–76.
- Wang S., Chi C., Wong Y. et al. Genital verrucous carcinoma is associated with lichen sclerosus: a retrospective study and review of the literature // J. Eur. Acad. Dermatol. Venereol. – 2010; 24: 815–9.
- Mannweiler S., Sygulla S., Winter E. et al. Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression // J. Am. Acad. Dermatol. – 2013; 69: 73–81.
- Fitspatrik T., Dzhonson R., Vul'f K. i dr. Dermatologija. Atlas-spravochnik. Per. s angl. Mak-Grou-Hill / M.: Praktika, 2015; s. 286–9.
- Jusupova L.A., Filatova M.A. Lokalizovannaja sklerodermija: diagnostika, klinika, lechenie // Lechaschij vrach. – 2014; 5: 51–5.
- Vilela F., Carneiro S., Ramos-e-Silva M. Treatment of morphea or localized scleroderma: review of the literature // J. Drugs Dermatol. – 2010; 9: 1213–9.
- Zwischenberger B., Jacobe H. A systematic review of morphea treatments and therapeutic algorithin // J. Am. Acad. Dermatol. – 2011; 65: 925–41.
- Funaro D., Lovett A., Leroux N. et al. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% vs. topical tacrolimus 0.1% in patients with vulvar lichen sclerosus // J. Am. Acad. Dermatol. – 2014; 71: 84–91.
- Valdivielso-Ramos M., Bueno C., Hernanz J. Significant improvement in extensive lichen sclerosus with tacrolimus oint- ment and PUVA // Am. J. Clin. Dermatol. – 2008; 9: 175–9.
- Virgili A., Lauriola M., Mantovani L. et al. Vulvar lichen sclerosus: 11 Women treated with tacrolimus 0.1% ointment // Acta Dermatol. Venerol. – 2007; 87: 69–72.
- Burrows L., Creasey A., Goldstein A. The treatment of vulvar lichen sclerosus and female sexual dysfunction // J. Sex Med. – 2011; 8: 219–22.
- Chi C., Kirtschig G., Baldo M. et al. Topical interventions for genital lichen sclerosus // Cochrane Database Syst. Rev. – 2011; 12: 40–58.
- Gunthert A., Faber M., Knappe G. et al. Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives // Eur. J. Obstet., Gynecol., Reprod. Biol. – 2008; 137: 56–60.
- Buense R., Duarte I., Bouer M. Localized scleroderma: assessment of the therapeutic response to phototherapy // An. Bras. Dermatol. – 2012; 87: 63–9.